IBDEI05W ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5695,0)
 ;;=E11.339^^36^407^75
 ;;^UTILITY(U,$J,358.3,5695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5695,1,3,0)
 ;;=3^Diabetes Type 2 w/ Moderate Nonprlf Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,5695,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,5695,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,5696,0)
 ;;=E11.341^^36^407^80
 ;;^UTILITY(U,$J,358.3,5696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5696,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonprlf Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,5696,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,5696,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,5697,0)
 ;;=E11.349^^36^407^81
 ;;^UTILITY(U,$J,358.3,5697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5697,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonprlf Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,5697,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,5697,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,5698,0)
 ;;=E11.351^^36^407^78
 ;;^UTILITY(U,$J,358.3,5698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5698,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,5698,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,5698,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,5699,0)
 ;;=E11.359^^36^407^79
 ;;^UTILITY(U,$J,358.3,5699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5699,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,5699,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,5699,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,5700,0)
 ;;=E11.610^^36^407^58
 ;;^UTILITY(U,$J,358.3,5700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5700,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,5700,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,5700,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,5701,0)
 ;;=E11.618^^36^407^55
 ;;^UTILITY(U,$J,358.3,5701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5701,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,5701,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,5701,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,5702,0)
 ;;=E11.620^^36^407^56
 ;;^UTILITY(U,$J,358.3,5702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5702,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,5702,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,5702,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,5703,0)
 ;;=E11.621^^36^407^67
 ;;^UTILITY(U,$J,358.3,5703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5703,1,3,0)
 ;;=3^Diabetes Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,5703,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,5703,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,5704,0)
 ;;=E11.622^^36^407^83
 ;;^UTILITY(U,$J,358.3,5704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5704,1,3,0)
 ;;=3^Diabetes Type 2 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,5704,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,5704,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,5705,0)
 ;;=E11.628^^36^407^82
 ;;^UTILITY(U,$J,358.3,5705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5705,1,3,0)
 ;;=3^Diabetes Type 2 w/ Skin Complications
 ;;^UTILITY(U,$J,358.3,5705,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,5705,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,5706,0)
 ;;=E11.630^^36^407^77
 ;;^UTILITY(U,$J,358.3,5706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5706,1,3,0)
 ;;=3^Diabetes Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,5706,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,5706,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,5707,0)
 ;;=E11.638^^36^407^76
 ;;^UTILITY(U,$J,358.3,5707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5707,1,3,0)
 ;;=3^Diabetes Type 2 w/ Oral Complications
 ;;^UTILITY(U,$J,358.3,5707,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,5707,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,5708,0)
 ;;=E11.69^^36^407^84
 ;;^UTILITY(U,$J,358.3,5708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5708,1,3,0)
 ;;=3^Diabetes Type 2 w/ Spec Complication NEC
 ;;^UTILITY(U,$J,358.3,5708,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,5708,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,5709,0)
 ;;=E11.8^^36^407^85
 ;;^UTILITY(U,$J,358.3,5709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5709,1,3,0)
 ;;=3^Diabetes Type 2 w/ Unspec Complications
 ;;^UTILITY(U,$J,358.3,5709,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,5709,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,5710,0)
 ;;=N18.1^^36^407^5
 ;;^UTILITY(U,$J,358.3,5710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5710,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,5710,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,5710,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,5711,0)
 ;;=N18.2^^36^407^6
 ;;^UTILITY(U,$J,358.3,5711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5711,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,5711,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,5711,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,5712,0)
 ;;=N18.3^^36^407^7
 ;;^UTILITY(U,$J,358.3,5712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5712,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,5712,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,5712,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,5713,0)
 ;;=N18.4^^36^407^8
 ;;^UTILITY(U,$J,358.3,5713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5713,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,5713,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,5713,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,5714,0)
 ;;=N18.5^^36^407^9
 ;;^UTILITY(U,$J,358.3,5714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5714,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,5714,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,5714,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,5715,0)
 ;;=N18.6^^36^407^87
 ;;^UTILITY(U,$J,358.3,5715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5715,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,5715,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,5715,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,5716,0)
 ;;=N18.9^^36^407^10
 ;;^UTILITY(U,$J,358.3,5716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5716,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,5716,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,5716,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,5717,0)
 ;;=G54.1^^36^407^96
 ;;^UTILITY(U,$J,358.3,5717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5717,1,3,0)
 ;;=3^Lumbosacral Plexus Disorders
 ;;^UTILITY(U,$J,358.3,5717,1,4,0)
 ;;=4^G54.1
 ;;^UTILITY(U,$J,358.3,5717,2)
 ;;=^5004008
 ;;^UTILITY(U,$J,358.3,5718,0)
 ;;=G56.11^^36^407^100
 ;;^UTILITY(U,$J,358.3,5718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5718,1,3,0)
 ;;=3^Median Nerve Lesions,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,5718,1,4,0)
 ;;=4^G56.11
 ;;^UTILITY(U,$J,358.3,5718,2)
 ;;=^5004021
 ;;^UTILITY(U,$J,358.3,5719,0)
 ;;=G56.12^^36^407^99
 ;;^UTILITY(U,$J,358.3,5719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5719,1,3,0)
 ;;=3^Median Nerve Lesions,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,5719,1,4,0)
 ;;=4^G56.12
 ;;^UTILITY(U,$J,358.3,5719,2)
 ;;=^5004022
 ;;^UTILITY(U,$J,358.3,5720,0)
 ;;=G56.21^^36^407^138
 ;;^UTILITY(U,$J,358.3,5720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5720,1,3,0)
 ;;=3^Ulnar Nerve Lesion,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,5720,1,4,0)
 ;;=4^G56.21
 ;;^UTILITY(U,$J,358.3,5720,2)
 ;;=^5004024
 ;;^UTILITY(U,$J,358.3,5721,0)
 ;;=G56.22^^36^407^137
 ;;^UTILITY(U,$J,358.3,5721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5721,1,3,0)
 ;;=3^Ulnar Nerve Lesion,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,5721,1,4,0)
 ;;=4^G56.22
 ;;^UTILITY(U,$J,358.3,5721,2)
 ;;=^5004025
 ;;^UTILITY(U,$J,358.3,5722,0)
 ;;=G56.31^^36^407^132
 ;;^UTILITY(U,$J,358.3,5722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5722,1,3,0)
 ;;=3^Radial Nerve Lesion,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,5722,1,4,0)
 ;;=4^G56.31
 ;;^UTILITY(U,$J,358.3,5722,2)
 ;;=^5004027
 ;;^UTILITY(U,$J,358.3,5723,0)
 ;;=G56.32^^36^407^131
